Esterified Estrogens Tablet shortage

To Be Discontinued

Esterified Estrogens Tablet is currently listed as To Be Discontinued in the FDA Drug Shortage Database. Reported reason: Not specified.

Therapeutic category

Endocrinology/Metabolism

Dosage form

Tablet

Routes

—

Last updated

07/29/2025

Strength variants

Not specified

Need sourcing help for Esterified Estrogens Tablet?

Get connected with licensed distributors and 503B compounders that can fulfill orders during active shortages. Verified suppliers, no spam.

Connect with a sourcing partner

Manufacturers reporting shortage

Pfizer Inc.800-533-4535
To Be Discontinued
Pfizer Inc.800-533-4535
To Be Discontinued
Pfizer Inc.800-533-4535
To Be Discontinued
Pfizer Inc.800-533-4535
To Be Discontinued

Reason for shortage

Not specified

ad slot 300x250

Related shortages in Endocrinology/Metabolism

Dextrose Monohydrate 10% Injection

Currently in Shortage

Category: Endocrinology/Metabolism
Reason: Not specified
Updated: 04/07/2026

Dextrose Monohydrate 5% Injection

Currently in Shortage

Category: Endocrinology/Metabolism
Reason: Not specified
Updated: 04/07/2026

Dextrose Monohydrate 5% Injection

Currently in Shortage

Category: Endocrinology/Metabolism
Reason: Not specified
Updated: 04/07/2026

Dextrose Monohydrate 5% Injection

Currently in Shortage

Category: Endocrinology/Metabolism
Reason: Not specified
Updated: 04/07/2026

Dextrose Monohydrate 5% Injection

Currently in Shortage

Category: Endocrinology/Metabolism
Reason: Not specified
Updated: 04/07/2026

Dextrose Monohydrate 10% Injection

Currently in Shortage

Category: Endocrinology/Metabolism
Reason: Not specified
Updated: 04/07/2026

This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.